Bright Minds Biosciences, Inc. (DRUG.CX)

108.64 -2.39 (-2.15%) CAD  |  CNSX  |  Mar 03, 15:48
More

Bright Minds Biosciences Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for DRUG.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Fennec Pharmaceuticals, Inc. Upgrade
Green Thumb Industries, Inc. Upgrade
Lowell Farms, Inc. --
Wesana Health Holdings, Inc. --
Sharp Therapeutics Corp. --

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade